United States : Merck Receives FDA Approval of PREVYMIS (letermovir) for Prevention of Cytomegalovirus (CMV) Infection and Disease in Adult Allogeneic Stem Cell Transplant Patients.
In: Mena Report, 2017-11-09
Online
Zeitungsartikel
Zugriff:
Titel: |
United States : Merck Receives FDA Approval of PREVYMIS (letermovir) for Prevention of Cytomegalovirus (CMV) Infection and Disease in Adult Allogeneic Stem Cell Transplant Patients.
|
---|---|
Link: | |
Zeitschrift: | Mena Report, 2017-11-09 |
Veröffentlichung: | 2017 |
Medientyp: | Zeitungsartikel |
ISSN: | 2219-0112 (print) |
Sonstiges: |
|